Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Venetoclax resistance: mechanistic insights and future strategies.
Cancer Drug Resist. 2022 May 6;5(2):380-400. doi: 10.20517/cdr.2021.125. eCollection 2022.
Cancer Drug Resist. 2022.
PMID: 35800373
Free PMC article.
Review.
Current Understanding of DDX41 Mutations in Myeloid Neoplasms.
Kim K, Ong F, Sasaki K.
Kim K, et al. Among authors: ong f.
Cancers (Basel). 2023 Jan 5;15(2):344. doi: 10.3390/cancers15020344.
Cancers (Basel). 2023.
PMID: 36672294
Free PMC article.
Review.
Item in Clipboard
Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation.
Short NJ, Ong F, Ravandi F, Nogueras-Gonzalez G, Kadia TM, Daver N, DiNardo CD, Konopleva M, Borthakur G, Oran B, Al-Atrash G, Mehta R, Jabbour EJ, Yilmaz M, Issa GC, Maiti A, Champlin RE, Kantarjian H, Shpall EJ, Popat U.
Short NJ, et al. Among authors: ong f.
Blood Adv. 2023 Jul 25;7(14):3573-3581. doi: 10.1182/bloodadvances.2022009632.
Blood Adv. 2023.
PMID: 37104058
Free PMC article.
Item in Clipboard
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents.
Short NJ, Muftuoglu M, Ong F, Nasr L, Macaron W, Montalban-Bravo G, Alvarado Y, Basyal M, Daver N, Dinardo CD, Borthakur G, Jain N, Ohanian M, Jabbour E, Issa GC, Qiao W, Huang X, Kanagal-Shamanna R, Patel KP, Bose P, Ravandi F, Delumpa R, Abramova R, Garcia-Manero G, Andreeff M, Cortes J, Kantarjian H.
Short NJ, et al. Among authors: ong f.
J Hematol Oncol. 2023 Jul 8;16(1):73. doi: 10.1186/s13045-023-01476-8.
J Hematol Oncol. 2023.
PMID: 37422688
Free PMC article.
Clinical Trial.
Item in Clipboard
Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
Chien KS, Ong F, Kim K, Li Z, Kanagal-Shamanna R, DiNardo CD, Takahashi K, Montalban-Bravo G, Hammond D, Sasaki K, Pierce SA, Kantarjian HM, Garcia-Manero G.
Chien KS, et al. Among authors: ong f.
Cancer Med. 2024 Mar;13(5):e7093. doi: 10.1002/cam4.7093.
Cancer Med. 2024.
PMID: 38497538
Free PMC article.
Item in Clipboard
Cite
Cite